FI820998L - 9-/2-(3-indolyl)etyl/-1-oxa-4,9-diazaspiro/5,5/undekan-3-oner - Google Patents
9-/2-(3-indolyl)etyl/-1-oxa-4,9-diazaspiro/5,5/undekan-3-onerInfo
- Publication number
- FI820998L FI820998L FI820998A FI820998A FI820998L FI 820998 L FI820998 L FI 820998L FI 820998 A FI820998 A FI 820998A FI 820998 A FI820998 A FI 820998A FI 820998 L FI820998 L FI 820998L
- Authority
- FI
- Finland
- Prior art keywords
- carbon atoms
- etyl
- oner
- undecan
- diazaspiro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/48—Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Photoreceptors In Electrophotography (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/246,459 US4332804A (en) | 1981-03-23 | 1981-03-23 | 9-[2-(3-Indolyl)ethyl]-1oxa-4,9-diazaspiro[5.5]undecan-3-ones |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI820998A7 FI820998A7 (fi) | 1982-09-24 |
| FI820998L true FI820998L (fi) | 1982-09-24 |
Family
ID=22930776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI820998A FI820998L (fi) | 1981-03-23 | 1982-03-22 | 9-/2-(3-indolyl)etyl/-1-oxa-4,9-diazaspiro/5,5/undekan-3-oner |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4332804A (cg-RX-API-DMAC10.html) |
| EP (1) | EP0061333B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JPS57169485A (cg-RX-API-DMAC10.html) |
| KR (1) | KR830009094A (cg-RX-API-DMAC10.html) |
| AT (1) | ATE17249T1 (cg-RX-API-DMAC10.html) |
| AU (1) | AU557094B2 (cg-RX-API-DMAC10.html) |
| BR (1) | BR8201589A (cg-RX-API-DMAC10.html) |
| DE (1) | DE3268225D1 (cg-RX-API-DMAC10.html) |
| DK (1) | DK129282A (cg-RX-API-DMAC10.html) |
| ES (1) | ES510649A0 (cg-RX-API-DMAC10.html) |
| FI (1) | FI820998L (cg-RX-API-DMAC10.html) |
| IE (1) | IE52652B1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL65310A (cg-RX-API-DMAC10.html) |
| NO (1) | NO820937L (cg-RX-API-DMAC10.html) |
| NZ (1) | NZ200085A (cg-RX-API-DMAC10.html) |
| PH (1) | PH17233A (cg-RX-API-DMAC10.html) |
| PL (1) | PL235561A1 (cg-RX-API-DMAC10.html) |
| PT (1) | PT74626B (cg-RX-API-DMAC10.html) |
| ZA (1) | ZA821929B (cg-RX-API-DMAC10.html) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4861880A (en) * | 1982-09-20 | 1989-08-29 | Pfizer Inc. | 1-phenyl-2(1H,3H)-indolone psycho-therapeutic agents |
| US4879391A (en) * | 1982-09-20 | 1989-11-07 | Pfizer Inc. | 1-Phenyl-2(1H,3H)-indolone psychotherapeutic agents |
| US4977178A (en) * | 1982-09-20 | 1990-12-11 | Pfizer Inc. | Method of treating anxiety and depression with 1-phenyl-2(1H,3H)-indolone psycho-therapeutic agents |
| GB8808433D0 (en) * | 1988-04-11 | 1988-05-11 | Merck Sharp & Dohme | Therapeutic agents |
| ATE348808T1 (de) | 2000-03-06 | 2007-01-15 | Acadia Pharm Inc | Azacyclische verbindungen zur verwendung in der behandlung von mit serotonin verwandten krankheiten |
| CN101050215A (zh) * | 2001-12-28 | 2007-10-10 | 阿卡蒂亚药品公司 | 作为单胺受体调节剂的螺氮杂环化合物 |
| US7253186B2 (en) * | 2002-06-24 | 2007-08-07 | Carl-Magnus Andersson | N-substituted piperidine derivatives as serotonin receptor agents |
| US7538222B2 (en) * | 2002-06-24 | 2009-05-26 | Acadia Pharmaceuticals, Inc. | N-substituted piperidine derivatives as serotonin receptor agents |
| BR0312217A (pt) * | 2002-06-24 | 2005-05-10 | Acadia Pharm Inc | Compostos, métodos de inibição da atividade/ativação de um receptor monoaminérgico e método de tratamento de condição doentia associada a um receptor de monoaminergético |
| EP1587789B1 (en) * | 2003-01-16 | 2008-09-03 | Acadia Pharmaceuticals Inc. | Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases |
| US7820695B2 (en) * | 2004-05-21 | 2010-10-26 | Acadia Pharmaceuticals, Inc. | Selective serotonin receptor inverse agonists as therapeutics for disease |
| US20050261278A1 (en) * | 2004-05-21 | 2005-11-24 | Weiner David M | Selective serotonin receptor inverse agonists as therapeutics for disease |
| US7790899B2 (en) * | 2004-09-27 | 2010-09-07 | Acadia Pharmaceuticals, Inc. | Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms |
| US7868176B2 (en) * | 2004-09-27 | 2011-01-11 | Acadia Pharmaceuticals, Inc. | Salts of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-y1)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and their preparation |
| AU2008228833B9 (en) | 2007-03-19 | 2013-10-24 | Acadia Pharmaceuticals Inc. | Combinations of 5-HT2A inverse agonists and antagonists with antipsychotics |
| HUE037639T2 (hu) * | 2007-09-21 | 2018-09-28 | Acadia Pharm Inc | Pimavanszerin együttes beadása más szerekkel |
| TWI685497B (zh) * | 2014-06-02 | 2020-02-21 | 西班牙商伊史帝夫製藥公司 | 具有多重模式抗疼痛活性的１-氧雜-４,９-二氮雜螺十一烷化合物之烷基衍生物 |
| JP6850282B2 (ja) | 2015-07-20 | 2021-03-31 | アカディア ファーマシューティカルズ インコーポレーテッド | Ｎ−（４−フルオロベンジル）−ｎ−（１−メチルピペリジン−４−イル）−ｎ’−（４−（２−メチルプロピルオキシ）フェニルメチル）カルバミドならびにその酒石酸塩および多形形態ｃを調製する方法 |
| SG11201803153RA (en) | 2015-11-16 | 2018-06-28 | Esteve Labor Dr | Oxadiazaspiro compounds for the treatment of drug abuse and addiction |
| US10953000B2 (en) | 2016-03-25 | 2021-03-23 | Acadia Pharmaceuticals Inc. | Combination of pimavanserin and cytochrome P450 modulators |
| WO2017165635A1 (en) | 2016-03-25 | 2017-09-28 | Acadia Pharmaceuticals Inc. | Combination of pimavanserin and cytochrome p450 modulators |
| EP3558311A1 (en) | 2016-12-20 | 2019-10-30 | Acadia Pharmaceuticals Inc. | Pimavanserin alone or in combination for use in the treatment of alzheimer's disease psychosis |
| WO2018200977A1 (en) | 2017-04-28 | 2018-11-01 | Acadia Pharmaceuticals Inc. | Pimavanserin for treating impulse control disorder |
| US20210077479A1 (en) | 2017-08-30 | 2021-03-18 | Acadia Pharmaceuticals Inc. | Formulations of pimavanserin |
| KR20200071107A (ko) | 2017-10-17 | 2020-06-18 | 에스테베 파마슈티칼스 에스에이 | (r)-9-(2,5-디플루오로페네틸)-4-에틸-2-메틸-1-옥사-4,9-디아자스피로[5.5]운데칸-3-온의 염 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3481942A (en) * | 1968-09-06 | 1969-12-02 | Smithkline Corp | Oxa-diazaspiro(4.5)decane compounds |
| US3574204A (en) * | 1969-07-03 | 1971-04-06 | Yoshitomi Pharmaceutical | Piperidine spiro compounds |
| CA952908A (en) * | 1970-02-27 | 1974-08-13 | Yoshitomi Pharmaceutical Industries | Benzodioxane derivatives |
| US3723442A (en) * | 1970-12-31 | 1973-03-27 | Yoshitomi Pharmaceutical | 3-oxo-1-oxa-4,8-diazaspiro(4.5)decanes |
| US4255432A (en) * | 1979-09-06 | 1981-03-10 | Syntex (U.S.A.) Inc. | 8-[2-3-Indolyl)ethyl]-1-oxa-3-,8-diazaspiro[4.5]decan-2-ones, pharmaceutical compositions thereof and methods of use thereof |
-
1981
- 1981-03-23 US US06/246,459 patent/US4332804A/en not_active Expired - Fee Related
-
1982
- 1982-02-22 BR BR8201589A patent/BR8201589A/pt unknown
- 1982-03-22 AU AU81769/82A patent/AU557094B2/en not_active Expired - Fee Related
- 1982-03-22 DE DE8282301460T patent/DE3268225D1/de not_active Expired
- 1982-03-22 ES ES510649A patent/ES510649A0/es active Granted
- 1982-03-22 IL IL65310A patent/IL65310A/xx unknown
- 1982-03-22 FI FI820998A patent/FI820998L/fi not_active Application Discontinuation
- 1982-03-22 NZ NZ200085A patent/NZ200085A/en unknown
- 1982-03-22 EP EP82301460A patent/EP0061333B1/en not_active Expired
- 1982-03-22 NO NO820937A patent/NO820937L/no unknown
- 1982-03-22 IE IE648/82A patent/IE52652B1/en unknown
- 1982-03-22 PT PT74626A patent/PT74626B/pt unknown
- 1982-03-22 KR KR1019820001218A patent/KR830009094A/ko not_active Withdrawn
- 1982-03-22 PL PL23556182A patent/PL235561A1/xx unknown
- 1982-03-22 ZA ZA821929A patent/ZA821929B/xx unknown
- 1982-03-22 AT AT82301460T patent/ATE17249T1/de not_active IP Right Cessation
- 1982-03-22 PH PH27035A patent/PH17233A/en unknown
- 1982-03-22 DK DK129282A patent/DK129282A/da not_active Application Discontinuation
- 1982-03-23 JP JP57044755A patent/JPS57169485A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP0061333B1 (en) | 1986-01-02 |
| DK129282A (da) | 1982-09-24 |
| NZ200085A (en) | 1985-07-12 |
| DE3268225D1 (de) | 1986-02-13 |
| AU8176982A (en) | 1982-09-30 |
| PH17233A (en) | 1984-07-03 |
| IE820648L (en) | 1982-09-23 |
| JPS57169485A (en) | 1982-10-19 |
| ATE17249T1 (de) | 1986-01-15 |
| KR830009094A (ko) | 1983-12-17 |
| NO820937L (no) | 1982-09-24 |
| IL65310A (en) | 1985-03-31 |
| ES8306373A1 (es) | 1983-06-01 |
| IE52652B1 (en) | 1988-01-06 |
| IL65310A0 (en) | 1982-05-31 |
| PT74626A (en) | 1982-04-01 |
| BR8201589A (pt) | 1983-02-08 |
| ES510649A0 (es) | 1983-06-01 |
| AU557094B2 (en) | 1986-12-04 |
| PL235561A1 (cg-RX-API-DMAC10.html) | 1982-10-25 |
| FI820998A7 (fi) | 1982-09-24 |
| EP0061333A1 (en) | 1982-09-29 |
| US4332804A (en) | 1982-06-01 |
| ZA821929B (en) | 1983-11-30 |
| PT74626B (en) | 1983-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI820998L (fi) | 9-/2-(3-indolyl)etyl/-1-oxa-4,9-diazaspiro/5,5/undekan-3-oner | |
| ES486349A1 (es) | Procedimiento para la preparacion de 5-(2-imidazolin-2-il)- aminopirimidinas | |
| DE3272476D1 (en) | Process for the preparation of indole derivatives, their use as intermediates, and 4-hydroxy indoles | |
| FI820295L (fi) | Nya kefemkompositioner och foerfarande foer deras framstaellning | |
| NZ213104A (en) | Tryptamine derivatives and pharmaceutical compositions | |
| IE820401L (en) | N-£4-(indolyl)-piperidino-alkyl|-benzimidazolines | |
| AU2636988A (en) | New 2-(piperazinyl)-2-substituted flavonoid derivatives, processes for preparing them and pharmaceutical compositions containing them | |
| ATE29721T1 (de) | 5-(4-vinyl- oder 4-ethynylbenzoyl)-1,2-dihydro-3h-pyrrolo-(1,2-a -pyrrol-1-carbosaeure und deren derivate. | |
| GR79170B (cg-RX-API-DMAC10.html) | ||
| NO822828L (no) | Analogifremgangsmaate ved fremstilling av terapeutisk virksomme 1-fenylindazol-3-on-forbindelser og deres salter | |
| SE8002545L (sv) | Arylsubstituerade furaner och sett for framstellning derav | |
| GR3006108T3 (cg-RX-API-DMAC10.html) | ||
| BG97231A (bg) | Тетрахидроизохинолинилкарбамати на 1,2,3,3а,8,8а-хексахидро- 1,3а,8-триметилпироло(2,3-в)индол | |
| DE3271277D1 (en) | Tropyl and pseudotropyl alkyl-benzoates and their use in migraine treatment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application lapsed |
Owner name: SYNTEX (USA) INC |